Recursion Pharmaceuticals (NASDAQ:RXRX) reported updated clinical data for its investigational treatment for familial ...
On November 2, 2026, a blog post published by an MIT research team became a major topic among AI researchers. It claimed that ...
Zacks Investment Research on MSN
Recursion's Q3 earnings beat estimates on Sanofi milestone revenues
Recursion Pharmaceuticals RXRX reported a loss of 22 cents per share in the third quarter of 2026, narrower than the Zacks ...
These two companies could move in different directions over the medium term.
Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.
President and Chief Executive Officer - Najat Khan ...
Recursion Q3 2026 earnings: clinical wins for REC-4881 and REC-1245, Sanofi progress, and cash runway to 2029.
A formalization of Kleene's second recursion theorem in the untyped lambda calculus yields a working Quine, with the proof carried out in the Rocq proof assistant. The approach highlights how the ...
Improvement" Take on a Life of Its Own?"If we keep having an AI improve itself, wouldn't explosive evolution (Recursive ...
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in ...
Understanding their capabilities can help developers and blockchain businesses choose tools that better match their technical ...
A Google DeepMind and Stanford study finds simple shapes like a red heart can push AI models such as GPT-5.4 and Claude ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results